申请人:Eisai R&D Management Co., Ltd.
公开号:US20150094328A1
公开(公告)日:2015-04-02
4-Azaindole derivatives which are modulators of muscarinic acetylcholine receptor (mAChR) M1 and which may be effective for the prevention or disease modifying or symptomatic treatment of cognitive deficits associated with neurological disorders such as Alzheimer-type dementia (AD) or dementia with Lewy bodies (DLB), and a pharmaceutical composition comprising a 4-azaindole derivative as an active ingredient.
4-氮杂吲哚衍生物是肌胆碱受体(mAChR)M1的调节剂,可能对预防或疾病修饰或症状性治疗与神经系统疾病如阿尔茨海默病(AD)或带有Lewy小体的痴呆症相关的认知缺陷有效,并且包括4-氮杂吲哚衍生物作为活性成分的药物组合物。